General MedicationsVAGINALStandard
CERVIDIL
DINOPROSTONE
Standard Dose
10MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview CERVIDIL is listed in Drugs@FDA under application 020411 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient DINOPROSTONE Form and strength INSERT, EXTENDED RELEASE;VAGINAL - 10MG Sponsor FERRING PHARMS INC Submission history Latest submission status date: 2020-07-07 00:00:00.
Structured Monograph
Clinical summary
Approval overview CERVIDIL is listed in Drugs@FDA under application 020411 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient DINOPROSTONE Form and strength INSERT, EXTENDED RELEASE;VAGINAL - 10MG Sponsor FERRING PHARMS INC Submission history Latest submission status date: 2020-07-07 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.